TY  - JOUR
AU  - Moura, David S
AU  - Peña-Chilet, Maria
AU  - Cordero-Varela, Juan Antonio
AU  - Alvarez-Alegret, Ramiro
AU  - Agra-Pujol, Carolina
AU  - Izquierdo, Francisco
AU  - Ramos, Rafael
AU  - Ortega-Medina, Luis
AU  - Martin-Davila, Francisco
AU  - Castilla-Ramirez, Carolina
AU  - Hernandez-Leon, Carmen Nieves
AU  - Romagosa, Cleofe
AU  - Vaz-Salgado, Maria Angeles
AU  - Lavernia, Javier
AU  - Bague, Silvia
AU  - Mayodormo-Aranda, Empar
AU  - Vicioso, Luis
AU  - Hernandez-Barcelo, Jose Emilio
AU  - Rubio-Casadevall, Jordi
AU  - de-Juan, Ana
AU  - Fiaño-Valverde, Maria Concepcion
AU  - Hindi, Nadia
AU  - Lopez-Alvarez, Maria
AU  - Lacerenza, Serena
AU  - Dopazo, Joaquin
AU  - Gutierrez, Antonio
AU  - Alvarez, Rosa
AU  - Valverde, Claudia
AU  - Martinez-Trufero, Javier
AU  - Martin-Broto, Javier
PY  - 2021
DO  - 10.1002/1878-0261.12996
UR  - http://hdl.handle.net/10668/17787
T2  - Molecular oncology
AB  - Predictive biomarkers of trabectedin represent an unmet need in advanced soft-tissue sarcomas (STS). DNA damage repair (DDR) genes, involved in homologous recombination or nucleotide excision repair, had been previously described as biomarkers of...
LA  - en
PB  - John Wiley & Sons Ltd.
KW  - gene signature
KW  - predictive biomarkers
KW  - trabectedin
KW  - Antineoplastic Agents, Alkylating
KW  - DNA Damage
KW  - DNA Repair
KW  - Dioxoles
KW  - Humans
KW  - Retrospective Studies
KW  - Sarcoma
KW  - Tetrahydroisoquinolines
KW  - Trabectedin
TI  - A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin.
TY  - research article
VL  - 15
ER  -